BioNTech SE – ADR (NASDAQ: BNTX) stock rose 5.64% after reporting its Q3 2021 earnings on November 9, 2021.
The company reported a net profit of €3.2 billion ($3.7 billion) for the three months from July to September 2021 compared to a €210 million ($243 million) loss in Q3 2020.
The German pharmaceutical company generated almost €6.1 billion ($7.1 billion) in revenues during the period compared to €67.5 million ($78 million) in a similar period last year.
Sponsored content
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Sponsored content
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Sponsored content
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Sponsored content
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Sponsored content
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
The pharmaceutical company’s windfall earnings are derived from its partnership with US pharma giant Pfizer in developing a COVID-19 vaccine that has been distributed globally since December 2020.
BioNTech’s total profit for the first nine months of the year adds up to €7.1 billion (8.2 billion) compared to a €351.7 million ($407 million) loss in a similar period last year.
In reaction to the Q3 earnings report, BioNTech shares rallied 5.64% during premarket trading.
*This is not investment advice.
BioNTech stock price.
Source: Tradingview
The BioNTech stock price rose 5.64% premarket to trade at $259.28, rising from Monday’s slicing price of $242.60.
Should you invest in BioNTech stock?
If you’re a smart investor, you will know that having large-cap stocks in your portfolio is vital. They are more mature companies, considered safer investments, trade with less volatility, have greater analyst coverage, and in most cases, have a steady dividend stream. Due to the current market environment, we think now is the perfect time to add large-cap stocks to your portfolio. But which large-cap shares should you buy? Our stock analysts regularly review the market and share their picks for some of the best large-caps to invest in.
Simon ist Autor und Analyst für den Bereich Finanzwesen und blickt auf über sechs Jahre professionelle Erfahrung als Trader zurück. Er absolvierte einen Bachelor in Mathematik und Informatik und hat eine Leidenschaft für die Finanzmärkte. Simon handelt FX, Rohstoffe und Aktien. Er konzentriert sich auf Price Action Trading.
